The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC)-Reference-Cited by-同舟云学术

The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC)

Published:2018-10-15 Issue:2 Volume:25 Page:839-843
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Pakarainen Tomi,Nevalainen Jaakko^ORCID,Talala Kirsi,Taari Kimmo,Raitanen Jani,Kujala Paula,Stenman Ulf-Håkan,Tammela Teuvo L.J.,Auvinen Anssi^ORCID

Funder

Academy of Finland

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening history and risk of death from prostate cancer: a nested case–control study within the screening arm of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC);Cancer Causes & Control;2023-12-08

3. A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer;European Urology;2023-10

4. Outcomes of Screening for Prostate Cancer Among Men Who Use Statins;JAMA Oncology;2022-01-01

5. Number of screening rounds attended and incidence of high‐risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC);Cancer;2020-10-13